Physician profile
Michael Brandon Mccollum
NPI 1720510753
$2,144.64
in general payments reported to CMS, 2019-2025
9 companies · $2,054 in 2025
The $2,054 reported for 2025 was more than what 94% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $90.87 · 2025: $2,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,218 · Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,218.10 |
| Food and Beverage | $926.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $1,606.43 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Ani Pharmaceuticals, INC. | $304.74 | 2025 | Purified Cortrophin Gel |
| Organogenesis INC. | $53.53 | 2024-2025 | Puraply Wound Matrix |
| Amgen INC. | $48.30 | 2024-2025 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $47.60 | 2025 | Nuzyra |
| Smith+Nephew, INC. | $26.58 | 2025 | Collagenase Santyl |
| Mimedx Group, INC. | $20.98 | 2025 | |
| Ethicon US, LLC | $19.79 | 2024 | Dermabond Prineo, Surgiflo Hemostatic Matrix, Vistaseal |
| Bioventus LLC | $16.69 | 2025 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mccollum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.